Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Index fund fees include management fees and other expenses. This brief breaks down what to expect and how fees impact long-term results.
14,694 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
As markets wobble in early 2026, investors are increasingly pursuing a hybrid approach that blends bonds and dividend...
Gold prices lower investors as tensions with Iran push the dollar higher and crude up, trimming bullion bets as trade...
Rising tensions over the Strait of Hormuz have sparked volatile moves in oil and equity markets as U.S. intelligence ...
Oil pushes toward $100 a barrel as Bitcoin struggles to extend its rally, with surges near $100 stalling the crypto b...
A look at five 2016 IPOs shows how a $1,000 investment in each would have fared through 2026, highlighting divergent ...
Kraft Heinz trimmed guidance after a challenging quarter, McCormick posted steady growth with margin pressure, and Ho...
AI momentum is reshaping markets. This guide dives into what best artificial intelligence stocks to buy now, how to s...
A down-market pullback can create a rare buying opportunity. This article explains how to spot a magnificent dividend...
U.S. stocks slide as oil prices push above $100 a barrel, triggering a risk-off mood that weighs on the S&P 500 and b...
Two well-positioned tech companies could be the catalysts for a multi-year fortune-building journey. This guide break...
Travel stocks among biggest movers climbed after President Trump teased possible Iran talks, signaling a temporary ea...